Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Capital Reinvestment Ratio
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥227.64 Million) in capital expenditures (CN¥35.55 Million). See debt-free asset ratio of Zhejiang Jingxin Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Jingxin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Zhejiang Jingxin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. Check 002020 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2025. For live market cap and broader valuation context, see Zhejiang Jingxin Pharmaceutical Co Ltd (002020) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | CN¥781.35 Million | CN¥202.85 Million | ▼ -24.8% |
| 2024 | 0.35x | CN¥726.16 Million | CN¥250.65 Million | ▼ -45.2% |
| 2023 | 0.63x | CN¥824.69 Million | CN¥519.51 Million | ▲ +4.6% |
| 2022 | 0.60x | CN¥855.78 Million | CN¥515.57 Million | ▼ -45.6% |
| 2021 | 1.11x | CN¥365.02 Million | CN¥404.43 Million | ▲ +70.2% |
| 2020 | 0.65x | CN¥513.21 Million | CN¥334.00 Million | ▲ +3.3% |
| 2019 | 0.63x | CN¥535.30 Million | CN¥337.33 Million | ▲ +36.2% |
| 2018 | 0.46x | CN¥523.40 Million | CN¥242.19 Million | ▲ +58.8% |
| 2017 | 0.29x | CN¥385.01 Million | CN¥112.19 Million | ▼ -22.7% |
| 2016 | 0.38x | CN¥252.69 Million | CN¥95.26 Million | ▼ -52.3% |
| 2015 | 0.79x | CN¥144.69 Million | CN¥114.31 Million | ▲ +75.5% |
| 2014 | 0.45x | CN¥210.49 Million | CN¥94.75 Million | ▼ -53.8% |
| 2013 | 0.98x | CN¥111.03 Million | CN¥108.28 Million | ▼ -29.6% |
| 2012 | 1.39x | CN¥60.28 Million | CN¥83.51 Million | ▲ +33.8% |
| 2011 | 1.04x | CN¥69.41 Million | CN¥71.86 Million | ▼ -60.4% |
| 2010 | 2.62x | CN¥59.55 Million | CN¥155.87 Million | ▲ +1655.7% |
| 2009 | 0.15x | CN¥135.38 Million | CN¥20.18 Million | ▼ -89.8% |
| 2008 | 1.46x | CN¥29.98 Million | CN¥43.81 Million | ▼ -32.9% |
| 2005 | 2.18x | CN¥61.82 Million | CN¥134.67 Million | ▼ -85.7% |
| 2004 | 15.26x | CN¥6.43 Million | CN¥98.11 Million | ▲ +889.6% |
| 2003 | 1.54x | CN¥46.18 Million | CN¥71.19 Million | ▲ +46.8% |
| 2002 | 1.05x | CN¥45.50 Million | CN¥47.79 Million | — |